452 related articles for article (PubMed ID: 25264240)
21. CD4/CD8 double-negative epidermotropic cutaneous T-cell lymphoma: an immunohistochemical variant of mycosis fungoides.
Hodak E; David M; Maron L; Aviram A; Kaganovsky E; Feinmesser M
J Am Acad Dermatol; 2006 Aug; 55(2):276-84. PubMed ID: 16844512
[TBL] [Abstract][Full Text] [Related]
22. Hypopigmented mycosis fungoides in childhood and adolescence: a long-term retrospective study.
Castano E; Glick S; Wolgast L; Naeem R; Sunkara J; Elston D; Jacobson M
J Cutan Pathol; 2013 Nov; 40(11):924-34. PubMed ID: 24320808
[TBL] [Abstract][Full Text] [Related]
23. Hypopigmented Mycosis Fungoides with Large Cell Transformation in a Child.
Pradhan D; Jedrych JJ; Ho J; Akilov OE
Pediatr Dermatol; 2017 Sep; 34(5):e260-e264. PubMed ID: 28804923
[TBL] [Abstract][Full Text] [Related]
24. Hyperpigmentation as a peculiar presentation of mycosis fungoides.
Lu YY; Wu CH; Lu CC; Hong CH
An Bras Dermatol; 2017; 92(5 Suppl 1):92-94. PubMed ID: 29267458
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
26. Mycosis fungoides in Arab children and adolescents: a report of 36 patients from Kuwait.
Nanda A; AlSaleh QA; Al-Ajmi H; Al-Sabah H; Elkashlan M; Al-Shemmari S; Demierre MF
Pediatr Dermatol; 2010; 27(6):607-13. PubMed ID: 21138468
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
Whittaker S; Ortiz P; Dummer R; Ranki A; Hasan B; Meulemans B; Gellrich S; Knobler R; Stadler R; Karrasch M
Br J Dermatol; 2012 Sep; 167(3):678-87. PubMed ID: 22924950
[TBL] [Abstract][Full Text] [Related]
28. A chart review of patients with early stage mycosis fungoides treated with psoralen plus UVA (PUVA).
Soung J; Muigai W; Amin N; Stern DK; Lebwohl MG
J Drugs Dermatol; 2005; 4(3):290-4. PubMed ID: 15898283
[TBL] [Abstract][Full Text] [Related]
29. Phototherapy of Mycosis Fungoides.
Hodak E; Pavlovsky L
Dermatol Clin; 2015 Oct; 33(4):697-702. PubMed ID: 26433842
[TBL] [Abstract][Full Text] [Related]
30. Treatment of stage Ia and Ib mycosis fungoides with psoralen UVA monotherapy: an observational study in tertiary hospitals in the Canary Islands.
Hernández Z; Peñate Y; Hernández-Machín B; Pérez-Méndez L; Suárez-Hernández J; Hernández J; Fernández-de-Misa R
Int J Dermatol; 2014 Nov; 53(11):1417-22. PubMed ID: 24697305
[TBL] [Abstract][Full Text] [Related]
31. Bath Psoralen-ultraviolet A and Narrowband Ultraviolet B Phototherapy as Initial Therapy for Early-stage Mycosis Fungoides: A Retrospective Cohort of 267 Cases at the University of Toronto.
Almohideb M; Walsh S; Walsh S; Shear N; Alhusayen R
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):604-612. PubMed ID: 28711574
[TBL] [Abstract][Full Text] [Related]
32. Nb-UVB and PUVA therapy in treating early stages of Mycosis Fungoides: A single-center cross-sectional study.
Zengarini C; Baruffaldi G; Piraccini BM; Bardazzi F; Mussi M; Hrvatin Stancic B; Pileri A
Photodermatol Photoimmunol Photomed; 2023 Sep; 39(5):435-440. PubMed ID: 36974002
[TBL] [Abstract][Full Text] [Related]
33. Phototherapy for hypopigmented mycosis fungoides in Asians.
Wongpraparut C; Setabutra P
Photodermatol Photoimmunol Photomed; 2012 Aug; 28(4):181-6. PubMed ID: 23017170
[TBL] [Abstract][Full Text] [Related]
34. Hypopigmented mycosis fungoides: a review of its clinical features and pathophysiology.
Furlan FC; Sanches JA
An Bras Dermatol; 2013; 88(6):954-60. PubMed ID: 24474105
[TBL] [Abstract][Full Text] [Related]
35. Psoralen plus ultraviolet A +/- interferon-alpha treatment resistance in mycosis fungoides: the role of tumour microenvironment, nuclear transcription factor-kappaB and T-cell receptor pathways.
Wozniak MB; Tracey L; Ortiz-Romero PL; Montes S; Alvarez M; Fraga J; Fernández Herrera J; Vidal S; Rodriguez-Peralto JL; Piris MA; Villuendas Deceased R
Br J Dermatol; 2009 Jan; 160(1):92-102. PubMed ID: 18945306
[TBL] [Abstract][Full Text] [Related]
36. Broad band UVA: a possible reliable alternative to PUVA in the treatment of early-stage mycosis fungoides.
El Mofty M; Ramadan S; Fawzy MM; Hegazy RA; Sayed S
Photodermatol Photoimmunol Photomed; 2012 Oct; 28(5):274-7. PubMed ID: 22971197
[TBL] [Abstract][Full Text] [Related]
37. Unusual variants of mycosis fungoides.
Abeldaño A; Arias M; Benedetti A; Ochoa K; Maskin M; Pellerano G; Kien MC; Chouela E
Skinmed; 2011; 9(4):218-22. PubMed ID: 21980706
[TBL] [Abstract][Full Text] [Related]
38. Poikilodermatous mycosis fungoides: a study of its clinicopathological, immunophenotypic, and prognostic features.
Abbott RA; Sahni D; Robson A; Agar N; Whittaker S; Scarisbrick JJ
J Am Acad Dermatol; 2011 Aug; 65(2):313-319. PubMed ID: 21529998
[TBL] [Abstract][Full Text] [Related]
39. Juvenile-onset hypopigmented mycosis fungoides mimicking vitiligo.
Ngo JT; Trotter MJ; Haber RM
J Cutan Med Surg; 2009; 13(4):230-3. PubMed ID: 19706233
[TBL] [Abstract][Full Text] [Related]
40. Hypopigmented mycosis fungoides: a 20-case retrospective series.
Amorim GM; Niemeyer-Corbellini JP; Quintella DC; Cuzzi T; Ramos-E-Silva M
Int J Dermatol; 2018 Mar; 57(3):306-312. PubMed ID: 29318586
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
